NCT00234988View on ClinicalTrials.gov

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

PHASE4CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

January 31, 2006

Conditions
Obesity
Interventions
DRUG

sibutramine hydochloride monohydrate

10 mg QD with the option to increase dose to 15 mg QD up until Week 4

Trial Locations (1)

60064

Global Medical Information - Abbott, North Chicago

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY